BRANFORD, CT – October 16, 2026 (STL.News) Azitra Inc. (NYSE American: AZTR), a clinical-stage biotechnology company developing treatments for dermatological conditions, announced Friday that it will implement a 1-for-10 reverse stock split, reducing its issued common shares from approximately 60.6 million to 6.06 million. The transaction is scheduled to become effective at 12:01 a.m. Eastern […]
This News Azitra (AZTR) Announces 1-for-10 Revers…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.